Comparing efficacy and safety of first-line treatment of metastatic renal cell carcinoma: A Bayesian network meta-regression analysis

Comparing efficacy and safety of first-line treatment of metastatic renal cell carcinoma: A Bayesian network meta-regression analysis

BackgroundThis Bayesian network meta-regression analysis provides a head-to-head comparison of first-line therapeutic immune checkpoint inhibitors (ICI) and tyrosine kinase inhibitors (TKI) combinations for metastatic renal cell carcinoma (mRCC) using median follow-up time as covariate.MethodsWe sea...

Full description

Bibliographic Details
Main Authors: Suyang Qin, Zhiyuan Xv, Xi Chen, Shurui Wang, Hai Lu, Jiaqi Li, Xinglin Guo, Jinghua Yang, Chengjiang Liu, Yaoguang Wang, Hongwu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
metastatic renal cell carcinoma
network meta-regression analysis
immune checkpoint inhibitors
tyrosine kinase inhibitors
efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1072634/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1072634/full

Similar Items